Evogene Ltd. (EVGN) Tops Q1 EPS by 7c

Evogene Ltd. (NYSE: EVGN) reported Q1 EPS of ($0.13), $0.07 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.65 million.

For earnings history and earnings-related data on Evogene Ltd. (EVGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• Pfizer lung cancer drug misses survival goal in Phase 3 trial